Detecting the signs of skin cancer: Dermalogica continue partnership with Skcin

by | May 9, 2022

Skin cancer is the most common cancer worldwide. In the UK alone, since the early 1990s rates of non-melanoma skin cancer have risen by 166%, with cases expected to reach almost 400,000 by 2025.

According to Cancer Research UK, 1 in 36 males and 1 in 47 females will be diagnosed with melanoma during their lifetime. Whilst skin cancer statistics are high, 90% of skin cancers are caused by exposure to ultraviolet radiation (UVR) and are preventable. In addition to this, 98% of skin cancers are curable or treatable if detected and diagnosed early.

 

Since 2018, Skcin have been ‘training eyes to save lives’ across the hair, beauty and healthcare industries nationwide. Skcin’s ‘MASCED’ (Melanoma and Skin Cancer Early Detection) accredited courses are designed to train professionals in how to spot the early signs and symptoms of skin cancer. Professional Skin Therapists are uniquely placed to observe any abnormalities or changes to their client’s skin – often in areas clients can’t see themselves. This puts therapists in a powerful position to spot the early signs and advise their client(s) to take action, which could drastically improve prognosis.

 

To support the charity in 2022, Dermalogica are continuing to provide funding for Skin Therapist employees in the UK & Ireland to undertake the MASCED training, as well as offering funding for the course to their salon partners. Annually, May marks Skin Cancer Awareness Month, and for 2022 Dermalogica will be continuing their work with charity Skcin to help educate on skin cancer awareness and sun safety, as well as raising vital funding for the charity through SPF sales. 20% of all SPF product purchases on dermalogica.co.uk and dermalogica.ie made in the first 20 days of May will be donated to Skcin.

 

“We are passionate about skills-led education programmes and the MASCED training is incredibly valuable for professionals who are perfectly placed to detect the signs of skin cancer and refer clients for potentially life-saving diagnosis. We are thrilled to be able to continue supporting SKCIN and the excellent work they do.”

– Candice Gardner, Education Manager for Dermalogica 

 

 “SKCIN are delighted to be continuing our partnership with Dermalogica. Our online MASCED training has been widely undertaken by all the Dermalogica staff and many of their skin therapist stockists. Dermalogica’s dedication and focus on education is perfectly aligned with our goal to train professionals in this sector in skin cancer surveillance. Together, we can be a powerful force tackling this national public health concern. With new skin cancer figures highlighting that 1 in 4 males and 1 in 5 females will be diagnosed with skin cancer in their lifetime, skin cancer is a growing problem in the UK. By Dermalogica funding more training and bespoke initiatives we can make huge impact. We are hugely grateful for this ongoing commitment to our work. Thank you Dermalogica!’

– Marie Tudor CEO of Skcin

 

Related reads:

Beauty technology: How to harness artificial intelligence in 2023

Beauty technology: How to harness artificial intelligence in 2023

The Global Beauty and Cosmetics Artificial Intelligence (A.I.) market was valued at $2.7bn last year, and it's expected to reach $13.3bn by 2030. With an increasing number of brands innovating in the beauty technology space, Sampo Parkkinen, CEO and co-founder...

For more information, check out:

THE NEWS YOU NEED TO KNOW

Stay on top of what's happening across the British beauty industry with our weekly news updates, delivered straight to your inbox.

Thanks for subscribing to receive news updates from the British Beauty Council.

Pin It on Pinterest

Share this on social: